Status:
NOT_YET_RECRUITING
Development of Voice Biomarkers of Frequent COVID-19 and Long Covid-related Symptoms Based on Data From Users of the Long COVID Companion App
Lead Sponsor:
Luxembourg Institute of Health
Conditions:
Long COVID
Eligibility:
All Genders
18+ years
Brief Summary
The LIH DDP research team focuses its research topics on vocal biomarkers and Long COVID, among others. Voice is indeed a promising tool to monitor health, as it contains many information on our healt...
Detailed Description
Five years after the start of the COVID-19 pandemic, it has been estimated that a mean of 10-20% of COVID-19 patients will develop Long COVID, which represents at least 65 million people worldwide. In...
Eligibility Criteria
Inclusion
- Adult (≥18 years old)
- Male or female
- People with persisting symptoms related to COVID-19 (With Long COVID diagnosis or not)
- Adequate understanding of one of the study languages (English, French, German)
- Electronically signed informed consent form
Exclusion
- ● No specific exclusion criteria
Key Trial Info
Start Date :
December 15 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2028
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT07156994
Start Date
December 15 2025
End Date
September 30 2028
Last Update
December 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
LIH
Strassen, Luxembourg, L-1445